Jazz Pharmaceuticals(JAZZ) - 2025 Q4 - Earnings Call Presentation

February 24, 2026 2025 Fourth Quarter and Full Year Financial Results Redefining Possibilities in Rare Disease Transforming Lives. Redefining Possibilities. Caution Concerning Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, statements related to: the Company's growth prospects and future financial and operating results, including the Company's 2026 financial guidance and the Company's expectations related thereto; anticipated multiple near-ter ...